Lipoprotein lipase (LPL), the enzyme that regulates the rate of hydrolysis of VLDL and triglycerides, is also involved in NAFLD development due to upregulation [4]. This evidence concerns the gene LPL and metabolic dysfunction-associated steatotic liver disease.